The GLP-1 receptor agonist exenatide failed to meet its primary outcome in a phase III trial of Parkinson's disease patients.

The FDA has approved a new type of painkiller that doesn't come with the risks of addiction and overdose associated with opioids.

In the latest episode of “The Oprah Podcast”, Oprah Winfrey delved into the world of GLP-1 medications like Ozempic, Wegovy, Mounjaro, and Zepbound, discussing their function, safety ...

The selected drugs treat conditions like diabetes, cancer and asthma WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- Medicare will soon negotiate prices for 15 more drugs as part of an effort to ...

Ozempic and similar weight loss drugs may lower risk of 42 health conditions, but also pose risks Ziyad Al-Aly - Washington University in St. Louis Jan 22, 2025 ...

The selected drugs treat conditions like diabetes, cancer and asthma WEDNESDAY, Jan. 22, 2025 (HealthDay News) -- Medicare will soon negotiate prices for 15 more drugs as part of an effort to reduce ...

The selected drugs treat conditions like diabetes, cancer and asthma Originally published on healthday.com, part of the BLOX Digital Content Exchange.

Semaglutide (known by its brandname Ozempic) has gained widespread attention ... The dose of semaglutide was gradually increased up to 1 mg or the maximum tolerated dose. During the last 4 ...